European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life
๐ #STATS2026 is underway!
๐ Over the next few days, participants will gain a deeper understanding of key statistical principles and learn how to apply them in research and clinical practice.
#CancerResearch#ClinicalTrials#StatisticalMethods
๐ข New study published!
Research led by Samantha Sodergren confirms that the EORTC QLQโC30 questionnaire, widely used in adults, is also valid & acceptable for adolescents with cancer.
๐ Read more: https://t.co/TrVcjJoXsR
#QualityofLife#CancerResearch@EORTC_QLG@SCSodergren
Join our team in #Brussels!
The EORTC Projects and Services department is looking for a new Project Manager.
Do you have a masterโs degree and 5 years of experience in a project management role? Are you looking for a new challenge?
Apply now: https://t.co/uxAjShZ7oA
#Jobs
๐ง This #WorldBrainTumourDay, discover how EORTCโs Brain Tumour Group advances neuro-oncology through trials, research & collaboration.
Learn more ๐ https://t.co/VfDMAjiiCA
Our Annual Report 2025 is now available, reflecting a year of progress, collaboration and continued commitment to independent clinical cancer research.
๐ Read more in our news article and explore the full report: https://t.co/gQRdTgWTMe
#CancerResearch
50 years of supporting independent cancer research.
Explore the story of the EORTC Cancer Research Fund, the people behind it, and its impact on cancer research since 1976.
๐ https://t.co/ynWmdNXvi7
#ECRF50
๐ New EORTC #QualityofLife Group publication in @eClinicalMed evaluates the contemporary clinical utility and measurement performance of the @EORTC QLQโBM22, a key tool for measuring quality of life in patients with bone metastases.
๐ https://t.co/ba4bDUEiyb
#CancerResearch
EORTC crossed the finish line at the #20kmBruxelles ๐โโ๏ธ๐โโ๏ธ
Great team effort from all colleagues!
With ECRF, the initiative continues beyond race day.
You can still support the effort.
๐ https://t.co/I4uR0AHARs
#RunforEORTC
Single-fraction or multi-fraction SBRT for oligometastatic disease?
EORTC SPRINT is exploring whether fewer treatment sessions could deliver the same efficacy while reducing burden for patients and healthcare systems.
#EORTC#SPRINT#ESTRO#Eยฒ-RADIatE #RadiationOncology#SBRT
EORTC is running the @20kmbru๐โโ๏ธ
Together with ECRF, weโre supporting independent cancer research.
๐ Every donation helps support research that advances cancer care
Join us ๐ Donate here: https://t.co/I4uR0AHARs
#RunForEORTC#ECRF#CancerResearch#ClinicalTrials
๐งช This Bladder Cancer Awareness Month, discover STARBURST 1 (EORTC-2418), advancing precision research in muscle-invasive bladder cancer under the SPECTA platform.
Many thanks to the supporters contributing to this important research.
#EORTCgenitourinary#BladderCancer
New Lung Cancer publication from the EORTC Lung Cancer Group.
Findings show targeted therapy is commonly used upfront in asymptomatic brain metastases, while approaches vary in symptomatic cases. Combination strategies are frequent in oligoprogression.
๐ https://t.co/pZ52AcbUrg
๐ข EORTC is hiring a Clinical Research Associate (CRA) to support international clinical trials in oncology.
Based in Brussels, the role involves collaboration with investigators and study teams across Europe.
๐ Apply: https://t.co/AEom2Vu95g
#ClinicalTrials#Oncology#Hiring
๐ข Late Rate Deadline tomorrow!
Final chance to join #STATS2026 and strengthen your understanding of clinical trial statistics.
๐ 9-12 June 2026
๐ Apply now: https://t.co/ifctrylMxZ
#CancerResearch#ClinicalTrials#StatisticalMethods
New EJC publication analysing 19 GI cancer trials (2010โ2023) from EORTC & Unicancer using the PRECISโ2 framework.
Findings show restrictive eligibility, moderate flexibilityuse of patient-centred endpoints, and pragmatic primary analyses.
๐ https://t.co/JYA2mmE6q2
๐ New @EORTC#QualityofLife Group study introduces novel timeโdynamic machine learning models to predict impaired HRQoL in early #BreastCancer, enabling more timely, targeted care โ while highlighting the need for fair AI.
๐ https://t.co/ba4bDUEiyb
#CancerCare@jmirpub